PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

199 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
161.
Ordelheide, A.-M. et al.: Granulocyte Colony-Stimulating Factor (G-CSF): A saturated fatty acid-induced myokine with insulin-desensitizing properties in humans. Mol. Metab. 5, 305-316 (2016)
162.
Ost, M.* et al.: Muscle mitochondrial stress adaptation operates independently of endogenous FGF21 action. Mol. Metab. 5, 79-90 (2016)
163.
Quarta, C. & Clemmensen, C.: Unforeseen role for glucocorticoids in combinatorial anti-obesity pharmacology. Mol. Metab. 5, 435-436 (2016)
164.
Raab, S.* et al.: Incretin-like effects of small molecule trace amine-associated receptor 1 agonists. Mol. Metab. 5, 47-56 (2016)
165.
Sánchez-Garrido, M.A. et al.: Fibroblast activation protein (FAP) as a novel metabolic target. Mol. Metab. 5, 1015-24 (2016)
166.
Schäfer, M. et al.: Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia. Mol. Metab. 5, 67-78 (2016)
167.
Schröder, T.* et al.: Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis. Mol. Metab. 5, 283-295 (2016)
168.
Ussar, S. ; Fujisaka, S.* & Kahn, C.R.*: Interactions between host genetics and gut microbiome in diabetes and metabolic syndrome. Mol. Metab. 5, 795-803 (2016)
169.
Ziegler, A.-G. et al.: Primary prevention of beta-cell autoimmunity and type 1 diabetes - the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives. Mol. Metab. 5, 255-262 (2016)
170.
Benazra, M.* et al.: A human beta cell line with drug inducible excision of immortalizing transgenes. Mol. Metab. 4, 916-925 (2015)
171.
Berti, L. et al.: Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes. Mol. Metab. 4, 519-527 (2015)
172.
Dyar, K.A. et al.: The calcineurin-NFAT pathway controls activity-dependent circadian gene expression in slow skeletal muscle. Mol. Metab. 4, 823-833 (2015)
173.
Hansen, J.S.* et al.: Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans. Mol. Metab. 4, 551-560 (2015)
174.
Heni, M. et al.: Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans. Mol. Metab. 4, 971-976 (2015)
175.
Hofmann, S.M. & Havel, P.J.*: The good, the bad, and the unknown: Fructose and FGF21. Mol. Metab. 4, 1-2 (2015)
176.
Jastroch, M. & Andersson, L.B.*: When pigs fly, UCP1 makes heat. Mol. Metab. 4, 359-362 (2015)
177.
Kahle-Stephan, M. et al.: High fat diet-induced modifications in membrane lipid and mitochondrial-membrane protein signatures precede the development of hepatic insulin resistance in mice. Mol. Metab. 4, 39-50 (2015)
178.
Keipert, S. et al.: Genetic disruption of uncoupling protein 1 in mice renders brown adipose tissue a significant source of FGF21 secretion. Mol. Metab. 4, 537-542 (2015)
179.
Migliorini, A. & Lickert, H.: Beyond association: A functional role for Tcf7l2 in β-cell development. Mol. Metab. 4, 365-366 (2015)
180.
Müller, T.D. et al.: Ghrelin. Mol. Metab. 4, 437–460 (2015)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... ▶▶ ▶▮